Lakefront Biotherapeutics (LKFT) Current Taxes (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported Current Taxes of $1.1 million for Q1 2026, up 420.54% year-over-year from $205117.5 in Q1 2025, and down 4.05% quarter-over-quarter from $1.1 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Current Taxes (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of Current Taxes data on file, last reported at $1.1 million in Q1 2026.
- Current Taxes for Q1 2026 came in at $1.1 million, up 420.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 420.54% YoY), and the FY2025 annual result was $1.1 million, up 318.23% from the prior year.
- Current Taxes eased to $1.1 million in Q1 2026 per LKFT's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Taxes peaked at $3.0 million in Q1 2022 and troughed at $60252.6 in Q4 2023.
- A 5-year average of $841687.0 and a median of $408000.2 in 2025 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2024 and 2026: Current Taxes tumbled 94.67% in 2024, then soared 420.54% in 2026.
- A 5-year view of Current Taxes shows it stood at $1.0 million in 2022, then sank by 94.22% to $60252.6 in 2023, then jumped by 341.61% to $266080.3 in 2024, then soared by 318.23% to $1.1 million in 2025, then decreased by 4.05% to $1.1 million in 2026.
- Business Quant data shows LKFT's Current Taxes at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $408000.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 10,460.56 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 408,000.23 |
| Jun 30, 2025 | 314,684.79 |
| Mar 31, 2025 | 205,117.47 |
| Dec 31, 2024 | 266,080.25 |
| Sep 30, 2024 | 237,215.41 |
| Mar 31, 2024 | 67,354.43 |
| Dec 31, 2023 | 60,252.63 |
| Sep 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Mar 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Jun 30, 2021 | 454,010.33 |
| Dec 31, 2020 | 1.49 Mn |
| Sep 30, 2020 | -1.28 Mn |
| Jun 30, 2020 | 1.39 Mn |
| Mar 31, 2020 | -331,181.71 |
| Dec 31, 2019 | 2.25 Mn |